Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
- 21 April 2008
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 178 (1), 9-19
- https://doi.org/10.1016/j.toxlet.2008.01.020
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
This publication has 16 references indexed in Scilit:
- Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicityInternational Journal of Pharmaceutics, 2007
- Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the NanoparticlesPharmaceutical Research, 2003
- Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastomaToxicology Letters, 2001
- Nanoparticulate systems for brain delivery of drugsAdvanced Drug Delivery Reviews, 2001
- Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated NanoparticlesPharmaceutical Research, 1999
- Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)Brain Research, 1995
- The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female ratArchives of Toxicology, 1988
- Sex differences in the cellular defence system against free radicals from oxygen or drug metabolites in ratArchives of Toxicology, 1984
- In Vivo Uptake of Polyisobutyl Cyanoacrylate Nanoparticles by Rat Liver Kupffer, Endothelial, andParenchymal CellsJournal of Pharmaceutical Sciences, 1984
- Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1982